SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/05/23 FSD Pharma Inc. 6-K 12/05/23 2:42K Blueprint/FA |
Document/Exhibit Description Pages Size 1: 6-K Current, Quarterly or Annual Report by a Foreign HTML 10K Issuer 2: EX-99.1 Press Release HTML 22K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of: December 2023
Commission File Number: 001-39152
FSD PHARMA INC. |
(Translation of registrant's name into English) |
199 Bay St., Suite 4000
Toronto, Ontario M5L 1A9, Canada
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
FSD Pharma Inc. (Registrant) |
| ||
| |||
Date: December 5, 2023 | By: | /s/ Nathan Coyle |
|
Nathan Coyle, Chief Financial Officer |
|
2 |
Exhibit |
| Description |
|
|
|
| Press Release – December 5, 2023 - FSD Pharma Inc. Announces Closing of Private Placement |
3 |
This ‘6-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 12/5/23 | None on these Dates | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/20/24 FSD Pharma Inc. 424B5 2/16/24 1:863K RDG Filings/FA |